Journal of Mid-life Health Journal of Mid-life Health
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission | Subscribe | Advertise Users Online: 109  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 




 
 Table of Contents 
CASE REPORT
Year : 2017  |  Volume : 8  |  Issue : 3  |  Page : 148-150  

Extensively metastasizing leiomyosarcoma: A diagnostic challenge


1 Department of Pathology, Dr. RML Hospital, PGIMER, New Delhi, India
2 Department of Neurosurgery, Dr. RML Hospital, PGIMER, New Delhi, India

Date of Web Publication15-Sep-2017

Correspondence Address:
Poojan Agarwal
House No. 249-E, Near Police Station, Nawada Bazar, Najafgarh, New Delhi - 110 043
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jmh.JMH_60_17

Rights and Permissions
   Abstract 

Uterine leiomyosarcoma (ULMS) is a rare malignancy of the female genital tract and carries an extremely poor 5-year survival rate. It is known to metastasize early and to distant sites owing to a high propensity for hematogeneous spread. Lung, peritoneum, liver, and bone are relatively common sites of metastasis. Patient age, tumor size, FIGO stage, and grade of the tumor are important criteria for predicting metastasis. The incidence of ULMS is increasing, probably due to the use of improved imaging techniques and as a result of cancer patients' prolonged life expectancy. An early well thought diagnosis is only made possible if even in otherwise seemingly unsuspected cases, the histopathology slides are extensively screened and the treating clinician is alerted timely. We hereby report a case of an elderly female who underwent hysterectomy for resection of multiple fibroids in the uterus and later presented with distant metastasis to brain with the erosion of overlying skull bone, chest wall, and lungs. Microscopic features along with an extensive immunohistochemistry panel were used to ascertain tumor origin.

Keywords: Hysterectomy, leiomyosarcoma, metastasis, pan cytokeratin, smooth muscle tumor, uterus


How to cite this article:
Ahuja A, Agarwal P, Sardana R, Bhaskar S. Extensively metastasizing leiomyosarcoma: A diagnostic challenge. J Mid-life Health 2017;8:148-50

How to cite this URL:
Ahuja A, Agarwal P, Sardana R, Bhaskar S. Extensively metastasizing leiomyosarcoma: A diagnostic challenge. J Mid-life Health [serial online] 2017 [cited 2022 Aug 15];8:148-50. Available from: https://www.jmidlifehealth.org/text.asp?2017/8/3/148/214945


   Introduction Top


Uterine leiomyosarcomas (ULMS) are uncommon malignant smooth muscle tumors constituting for about 1% of all uterine malignancies.[1] ULMS have a high propensity for hematogeneous spread, most commonly to the lungs, followed by liver and peritoneal cavity.[2] Intracranial and soft tissue metastasis are extremely rare with only a handful of case reports available in literature.[2],[3] An accurate early diagnosis of ULMS is essential as these patients have a dismal prognosis and a high recurrence (45%–75%) rate even when the disease is confined to the uterus.[4] Tirumani et al. studied the metastatic pattern of 113 ULMS and found 81.4% cases with distant metastases and 50% patients had local recurrence.[5] Radical hysterectomy followed by radiotherapy and chemotherapy is the mainstay of the current treatment protocol, but despite patient tailored and intensified therapy, the outcome is poor.[6] Fine needle aspiration (FNA) findings of metastatic ULMS have seldom been discussed at unusual sites.[7],[8],[9] We report a case of extensively metastasizing leiomyosarcoma that was under-diagnosed on hysterectomy.


   Case Report Top


A 60-year-old woman came with the complaints of easy fatigability, persistent dull aching headache for the past 3 months with intermittent episodes of aggravation. Headache was predominantly localized on the right side and throbbing in nature. She also had a nodular growth over the right forehead measuring about 2.5 cm × 2.5 cm for 3 months. It began as a small nodule of pea size and progressed to about 1 cm × 1 cm. Due to pain over the swelling, she went to a local practitioner and got it excised. However, the swelling recurred and grew to its present size over a period of 1½ months. There was no alteration in appetite, bowel, and bladder habits or weight loss. She had a history of total abdominal hysterectomy done for multiple uterine fibroids, 6 months back.

Local examination of forehead swelling showed a nodular surface with an overlying scar mark of previous excision [Figure 1]a. The swelling was fixed, nontender, and nonpulsatile on palpation. The patient also had a firm, fixed swelling over right chest wall measuring about 4 cm × 4 cm [Figure 1]c. There was no other palpable organomegaly. Her serum chemistry and blood investigations were within normal limits. Contrast-enhanced computed tomography (CECT) of head revealed a large heterogeneously enhancing mass of approximately 5 cm × 4 cm in the right frontal region. The lesion caused destruction of both outer and inner tables of frontal bone along with inward compression of the right frontal lobe [Figure 1]b. CECT chest and abdomen also revealed a heterogeneously enhancing mass lesion measuring 5.7 cm × 4.1 cm × 3.5 cm in superior and posterobasal segment of the right lower lobe with evidence of infiltration into right branch of inferior pulmonary vein. Multiple nodular opacities with few showing spiculations were seen in bilateral upper lobes [Figure 1]d. Also seen was a pleura-based soft tissue dense enhancing mass involving the right posterolateral chest wall with the destruction of right 10th rib [Figure 1]e. There was evidence of contiguous infiltration of the mass into overlying subcutaneous fat and right posterolateral chest wall.
Figure 1: (a) Nodular forehead swelling with scar of the previous resection (b) Magnetic resonance imaging brain-expansile lytic lesion involving the right frontal bone. (c) Firm, fixed, right chest wall swelling. (d) Contrast-enhanced computed tomography abdomen-pleura-based enhancing mass lesion involving chest wall, causing the destruction of the 10th rib. (e) Contrast-enhanced computed tomography chest: Heterogeneously enhancing mass in the right lower lobe of lung along with multinodular opacities with spiculations in bilateral upper lobes

Click here to view


Multiple FNAs were performed from forehead and lateral chest wall nodular masses. Smears prepared from both sites showed similar morphology. Pleomorphic tumor cells were seen predominantly in cohesive overlapping clusters with hyperchromatic oval to bizarre nuclei. At places, the cells were seen embedded in a pink matrix material. Features were those of a poorly differentiated malignant tumor. Immunocytochemistry could not be performed, as the patient did not consent for a repeat FNA. The patient was asked to retrieve paraffin blocks from previously resected forehead nodule. Reviewed histomorphology and serial sectioning revealed elongated fascicles of a cellular spindle tumor with cells displaying moderate anisokaryosis along with occasional bizarre nuclear form. Mitosis was evident along with foci of necrosis. Lymphovascular emboli were not identified [Figure 2]a,[Figure 2]b,[Figure 2]c,[Figure 2]d. Overlying skin was free of tumor. A panel of immunohistochemical stains was put up for further characterization. Tumor cells were strongly positive for vimentin, muscle specific antigen (MSA), and smooth muscle actin (SMA) along with distinct perinuclear dot positivity for pan cytokeratin (pan-CK) [Figure 3]a,[Figure 3]b,[Figure 3]c,[Figure 3]d. Cells were negative for desmin, S-100, and CD34. A final diagnosis of metastatic leiomyosarcoma was given. In an attempt to locate the primary and considering patients sequential history, her previous hysterectomy specimen was retrieved and extensively regrossed. Serial sections revealed leiomyoma with two 10 mm and 7 mm foci showing moderate nuclear atypia, stippled necrosis, and evident mitosis; consistent with leiomyosarcoma. Hence, a final impression of ULMS with metastasis to chest wall and forehead was made. The patient was started on a chemotherapeutic regimen comprising of three cycles of gemcitabine/docetaxel, followed by intensity modulated radiation therapy to abdomen. The patient became symptomatically better for a few weeks. However, a 6-month follow-up computed tomography scan chest, done posttherapy was suggestive of approximately 20% increase in size of mass in lower lobe and right chest wall; indicating progressive disease. The patient is now further planned for intensified chemotherapy regimen.
Figure 2: (a) Cellular spindle cell neoplasm (H and E, ×20). (b) Perivascular arrangement of tumor cells (H and E, ×20). (c) Tumor cells showing moderate pleomorphism (H and E, ×40). (d) Scattered multinucleate tumor cells (arrowhead) and mitotic figures (arrow) (H and E, ×40)

Click here to view
Figure 3: Immunohistochemistry for (a) Vimentin (b) Muscle specific antigen (c) Smooth muscle actin shows membranous positivity. (d) Pan cytokeratin shows perinuclear dot positivity

Click here to view



   Discussion Top


Diagnosis and management of ULMS can be challenging as disease presentation and prognosis varies considerably from patient to patient. However, literature available for studying the same is scant, and most studies are retrospective probably due to disease rarity and dynamic nature.[5],[6] Tirumani et al. and Bernstein-Molho et al. observed that diagnosis of ULMS often occurs in retrospect after surgical resection of a presumed benign uterine neoplasm, as was seen in our case.[5],[10] Therefore, patients many a times do not undergo preoperative staging work up, leading to inadequate management.

A surgical pathologist has a crucial role in these situations. Extensive sampling, especially of unusual areas, is mandatory to elucidate the nature of the tumor. The final diagnosis of ULMS is based on the assessment of three major histologic features: increased mitotic activity (≥10/10 HPF), nuclear atypia, and tumor cell necrosis. However, it is prudent to point out differential diagnosis is difficult when a variant of leiomyosarcoma shows unusual morphological features or if morphology mimics other mesenchymal sarcomas encountered in the uterus such as endometrial stromal sarcoma, malignant melanoma, tumors with rhabdoid differentiation, and even poorly differentiated carcinomas.[11] Immunohistochemistry for vimentin, SMA, and MSA is characteristically positive in leiomyosarcomas, which further confirms tumor origin and diagnosis.[12] In addition, in the present case, an aberrant strong positivity of pan-CK was observed which is highly unusual for a sarcoma. CK positivity has been described in few reports as a “potentially serious diagnostic pitfall” in diagnosing a malignant spindle cell tumor.[13]

We describe a case of ULMS that metastasized to unusual locations and required multidisciplinary approach; clinical history, critical analysis of FNA slides and review of archival material and assay of histomorphology to arrive at a confirmatory diagnosis. The present case highlights the importance of close microscopic examination in an otherwise clinically unsuspected case.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Nucci MR, Olivia E, editors. Pure mesenchymal and mixed mullerian tumors of the uterus. In: Gynecologic Pathology. China: Churchill Livingstone, Elsevier; 2009.  Back to cited text no. 1
    
2.
Yip CM, Yang KC, Lo YS, Liao WC, Chen JY, Hsu SS, et al. Skull metastasis from uterine leiomyosarcoma: A case report. Acta Neurol Taiwan 2006;15:109-13.  Back to cited text no. 2
    
3.
Barbetakis N, Paliouras D, Asteriou C, Samanidis G, Kleontas A, Anestakis D, et al. Cutaneous skull metastasis from uterine leiomyosarcoma: A case report. World J Surg Oncol 2009;7:45.  Back to cited text no. 3
    
4.
Penel N, Italiano A, Isambert N, Bompas E, Bousquet G, Duffaud F, et al. Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy. Ann Oncol 2010;21:1361-5.  Back to cited text no. 4
    
5.
Tirumani SH, Deaver P, Shinagare AB, Tirumani H, Hornick JL, George S, et al. Metastatic pattern of uterine leiomyosarcoma: Retrospective analysis of the predictors and outcome in 113 patients. J Gynecol Oncol 2014;25:306-12.  Back to cited text no. 5
    
6.
Lusby K, Savannah KB, Demicco EG, Zhang Y, Ghadimi MP, Young ED, et al. Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: A single institution's experience. Ann Surg Oncol 2013;20:2364-72.  Back to cited text no. 6
    
7.
Persson PG, Domanski HA. Fine needle aspiration cytology of uterine leiomyosarcoma metastatic to the tongue. Acta Cytol 1998;42:1066-7.  Back to cited text no. 7
    
8.
Nemenqani D, Yaqoob N, Khoja H. Leiomyosarcoma metastatic to the thyroid diagnosed by fine needle aspiration cytology. J Pak Med Assoc 2010;60:307-9.  Back to cited text no. 8
    
9.
Pappa L, Zagorianakou N, Kitsiou E, Sintou-Mantela E, Bafa M, Malamnou-Mitsi V, et al. Breast metastasis from uterine leiomyosarcoma diagnosed by fine needle aspiration: A case report. Acta Cytol 2008;52:485-9.  Back to cited text no. 9
    
10.
Bernstein-Molho R, Grisaro D, Soyfer V, Safra T, Merimsky O. Metastatic uterine leiomyosarcomas: A single-institution experience. Int J Gynecol Cancer 2010;20:255-60.  Back to cited text no. 10
    
11.
Toledo G, Oliva E. Smooth muscle tumors of the uterus: A practical approach. Arch Pathol Lab Med 2008;132:595-605.  Back to cited text no. 11
    
12.
Chu PG, Arber DA, Weiss LM, Chang KL. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: An immunohistochemical comparison of 34 cases. Mod Pathol 2001;14:465-71.  Back to cited text no. 12
    
13.
Iwata J, Fletcher CD. Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: A systematic study of 100 cases. Pathol Int 2000;50:7-14.  Back to cited text no. 13
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]


This article has been cited by
1 Oncological Properties of Intravenous Leiomyomatosis: Involvement of Mesenchymal Tumor Stem-Like Cells
Saya Tamura, Takuma Hayashi, Hideki Tokunaga, Nobuo Yaegashi, Kaoru Abiko, Ikuo Konishi
Current Issues in Molecular Biology. 2021; 43(2): 1188
[Pubmed] | [DOI]
2 Skull Metastasis From Uterine Leiomyosarcoma, a Rare Presentation for a Rare Tumor: A Case Report and Review of the Literature
Alessandro Rizzo, Maria Concetta Nigro, Vania Ramponi, Carmine Gallo, Anna Myriam Perrone, Pierandrea De Iaco, Giovanni Frezza, Damiano Balestrini, Maika Di Benedetto, Jarno Morbiducci, Maria Abbondanza Pantaleo, Margherita Nannini
Frontiers in Oncology. 2020; 10
[Pubmed] | [DOI]



 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Case Report
   Discussion
    References
    Article Figures

 Article Access Statistics
    Viewed2664    
    Printed98    
    Emailed0    
    PDF Downloaded220    
    Comments [Add]    
    Cited by others 2    

Recommend this journal